{"content":[{"text":"CONFIDENTIAL","bbox":{"left":0.701589,"top":0.039832,"width":0.147853,"height":0.019581}},{"text":"1","bbox":{"left":0.151018,"top":0.096887,"width":0.014906000000000003,"height":0.026099999999999998}},{"text":"The technology","bbox":{"left":0.246153,"top":0.096887,"width":0.198629,"height":0.026099999999999998}},{"text":"The Debrisoft monofilament debridement pad (Activa Healthcare) is a sterile, \n single-use pad for nurses and other healthcare professionals to use on adults \n and children to remove devitalised tissue, debris, and hyperkeratotic skin \n caused by chronic and acute wounds. The Debrisoft monofilament \n debridement pad (referred to in the remainder of this document as the \n Debrisoft pad) is used to ensure the wound bed is not obscured, aiding full \n assessment and further treatment if needed.","bbox":{"left":0.151018,"top":0.137618,"width":0.689374,"height":0.16708000000000003}},{"text":"The Debrisoft pad is 10×10 cm and is made of monofilament polyester fibres \n with a reverse side of polyacrylate. The monofilament fibres are cut with \n angled tips designed to penetrate irregularly shaped areas and remove \n devitalised skin and wound debris.","bbox":{"left":0.151018,"top":0.323916,"width":0.6816800000000001,"height":0.09340100000000001}},{"text":"To use, the Debrisoft pad is moistened with sterile water or saline and then \n folded and wiped across the wound with an appropriate amount of pressure. \n Cellular debris, slough (necrotic tissue), exudate and hyperkeratotic tissue \n become integrated into the monofilaments and are therefore removed from \n the wound site. The Debrisoft pad is intended for use without analgesia, and \n the process takes, on average, 2–4 minutes. A new Debrisoft pad is needed \n for each separate area of skin being treated. For large areas, more than 1 pad \n may be needed. Expert advisers stated that the Debrisoft pad should be used \n only after a registered healthcare professional has made a clinical \n assessment.","bbox":{"left":0.151018,"top":0.436499,"width":0.696056,"height":0.2409249999999999}},{"text":"2","bbox":{"left":0.151018,"top":0.695778,"width":0.014906000000000003,"height":0.026100000000000012}},{"text":"Proposed use of the technology","bbox":{"left":0.246153,"top":0.695778,"width":0.408974,"height":0.026100000000000012}},{"text":"2.1 Disease or condition \n The types of chronic wounds that may be relevant for debridement include \n pressure ulcers, leg ulcers and diabetic foot ulcers and skin conditions \n associated with lymphoedema. The types of acute wounds that may be \n relevant include burns, surgical dehiscences and haematomas. \n Page 2 of 85 \n Assessment report overview: The Debrisoft monofilament debridement pad for use in acute \n and chronic wounds \n Date: October 2013","bbox":{"left":0.151018,"top":0.743237,"width":0.698202,"height":0.20127099999999998}}],"images_bbox":[],"images_bbox_not_text_overlap":[]}